---
title: Adragos Pharma vs Halo Pharma
slug_a: adragos-pharma
slug_b: halo-pharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/adragos-pharma/halo-pharma
---

# Adragos Pharma vs Halo Pharma

Side-by-side profile data from each company listing on this directory.

## Adragos Pharma

- Profile: [/companies/adragos-pharma](/companies/adragos-pharma)

Adragos Pharma — Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.

Services: 17. Modalities: 2. Indications: 1. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (17).

### Services

- HPAPI Manufacturing (High-Potency)
- Monoclonal Antibody (mAb) Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Secondary Packaging & Labeling
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- Oral Solid Dose (OSD)
- Expression: Mammalian
- HPAPI
- DEA licensed

## Halo Pharma

- Profile: [/companies/halo-pharma](/companies/halo-pharma)

Halo Pharma — Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program.

Services: 10. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (10).

### Services

- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cartridge Filling
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Prefilled Syringes (PFS)
- Cartridges